Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Filgrastim × Clear all

NCT01266447 2019-08-08

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

27 enrolled 11 charts

Uterine Cervical Neoplasms

NCT00003065 2014-01-06

Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix

Phase 2 Completed

Uterine Cervical Neoplasms